NCT00481923View on ClinicalTrials.gov

Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions

Obesity

Interventions

DRUG

rimonabant (SR141716)

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Guildford

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY